ToxIC Novel Opioid and Stimulant Exposures
The ToxIC Registry has developed an enhanced sentinel event detection instrument to identify novel opioids and psychostimulants encountered by medical toxicologists during patient consultations and toxicology evaluations.
ToxIC Novel Opioid and Stimulant Exposures (ToxIC NOSE) is two-year project that will allow ACMT to enhance reporting to its members and the Opioid Response Network (ORN) regarding novel opioids and psychostimulants. Using data from the ToxIC Registry, quarterly reports will highlight cases involving novel and emerging exposures in approximately 35 sites across the United States.
As part of this project, a quarterly report will be released to highlight a recent case or topic.
Read the 1st Quarterly ToxIC NOSE Report on the transmission of opioids in breast milk.
Read the 2nd Quarterly ToxIC NOSE Report on Phencyclidine (PCP) and emerging PCP analogs.
Funding for this initiative was made possible (in part) by grant number 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.